Voting Rights Announcements | 12 March 2009 14:30


STRATEC Biomedical Systems AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical Systems AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)

Release of a Voting Rights announcement, transmitted by DGAP - a company of
EquityStory AG.
The issuer is solely responsible for the content of this announcement.
----------------------------------------------------------------------


Threadneedle Investment Funds ICVC, London, UK, has notified us pursuant to
§ 21 sec. 1 WpHG on 12 March 2009, that on 10 March 2009 the share of
voting rights in STRATEC Biomedical Systems AG, Birkenfeld, Germany, ISIN:
DE0007289001 went above the threshold of 10% and that the percentage of
voting rights on that day amounted to 10,056% (1,148,959 shares). These
voting rights are held by subfunds of Threadneedle Investment Funds ICVC.

Threadneedle Investment Services Limited, London, UK, has notified us
pursuant to § 21 sec. 1 WpHG on 12 March 2009, that on 10 March 2009 the
share of voting rights in STRATEC Biomedical Systems AG, Birkenfeld,
Germany, ISIN: DE0007289001 went above the threshold of 10% and that the
percentage of voting rights on that day amounted to 10,056% (1,148,959
shares). Pursuant to § 22 para. 1 sent. 1 No. 6 WpHG, these voting rights
are in their entirety attributable to Threadneedle Investment Services
Limited, London, UK. These voting rights are held by subfunds of
Threadneedle Investment Funds ICVC.

12.03.2009  Financial News transmitted by DGAP
----------------------------------------------------------------------
 
Language:     English
Issuer:       STRATEC Biomedical Systems AG
              Gewerbestraße 37
              75217 Birkenfeld
              Deutschland
Internet:     www.stratec-biomedical.de
 
End of News                                     DGAP News-Service
 
---------------------------------------------------------------------------